The First Affiliated Hospital of Guangdong Pharmaceutical University
Guangzhou, Guangdong, China
Key Insight: Operating with 1,789 staff members, including 238 senior-titled professionals, the hospital has an expansive 103,000 square meter construction area and is currently undergoing significant expansion in the Nonglin Campus.
A Hub for Clinical Pharmacy &
Metabolic Disease Research
The First Affiliated Hospital of Guangdong Pharmaceutical University is a leader in integrating traditional Chinese medicine with modern western medical practices. The institution stands out for its exceptional academic ranking, placing in the top 5% nationally for its Integrated Chinese-Western Medicine discipline.
The hospital hosts vital national platforms, including two key laboratories designated by the National Administration of Traditional Chinese Medicine (NATCM) focusing on lipid metabolism and hyperlipidemia, firmly establishing it as a powerhouse for both clinical care and pharmaceutical innovation.
Host Unit
NATCM International Cooperation Base for Metabolic Diseases
Institutional Status & External Evidence
National Key Disciplines & Specialties
Integrated Chinese-Western Medicine
National TCM Admin Key Discipline. Ranked 1st in Guangdong, with a core focus on metabolic disease prevention and treatment.
Clinical Pharmacy
National Clinical Key Specialty. The first in the province to deploy full-time clinical pharmacists and a designated MOH pilot institution.
Metabolic Diseases
Provincial leader in the integrated treatment of hyperlipidemia, diabetes, gout, and fatty liver, backed by a Provincial Key Laboratory.
Cardiovascular Medicine
Provincial 'Five-in-One' key specialty, operating the National Atrial Fibrillation Center and China Heart Rehabilitation Center.
Stomatology
Provincial-level key specialty providing comprehensive oral surgery, prosthodontics, orthodontics, and cosmetic dentistry.
NATCM Key Laboratories
Housing two exclusive national labs focusing on 'Hyperlipidemia Liver-Regulating' and 'Lipid Metabolism' research.
Medical & Research Innovation Hubs
International Academic Cooperation & Exchange
As a public tertiary general hospital, its core mission centers on serving the domestic population. However, it plays a vital role in international academic exchange through specialized research platforms, driving global collaboration in metabolic disease prevention.
- Designated as the NATCM "International Cooperation Base for TCM Prevention and Treatment of Metabolic Diseases (Guangdong)".
- Member of the Guangdong-Hong Kong-Macao Phase I & Bioequivalence (BE) Clinical Research Joint Platform.
- Promoting cross-border drug clinical research cooperation within the Greater Bay Area.
Global Excellence Standard
Leveraging its national-level laboratories and elite clinical pharmacy framework, the hospital actively contributes to establishing internationally recognized protocols for integrated TCM-Western metabolic treatments.
Research Powerhouse
With over 440 patent authorizations and 598 research projects, the institution drives global innovation in lipid metabolism and pharmaceutical sciences.
Source & Verification
Hospital entity information on this page is maintained from official institutional and government-level sources reviewed by MedBridge. Departmental services, rankings, certifications, and operational information may change over time and should be confirmed with the institution before making a medical decision.